| Market Cap | ₹21Cr |
| ROE | 8.05% |
| P/E Ratio(TTM) | 20.70 |
| EPS(TTM) | 3.42 |
| P/B Ratio | 1.96 |
| Dividend Yield | 0.00% |
| Industry P/E | 41.03 |
| Book Value | 36.08 |
| Debt to Equity | 0.36 |
| Face Value | 10 |
| Parent Organisation | Ishita Drugs & Industries Limited |
| Managing Director | Mr. Jagdish Agrawal |
| BSE Symbol | 524400 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 78.26 | ||
| Neuland Laboratories | NA (0.00%) | 128.24 | ||
| Jubilant Pharmova | NA (0.00%) | 39.67 | ||
| Acutaas Chemicals | NA (0.00%) | 66.42 |